|
End-of-day quote
Taiwan S.E.
2026-10-30
|
5-day change | 1st Jan Change | ||
| 47.80 TWD | -2.45% |
|
-3.82% | -22.53% |
| 10-06 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 09-09 | EirGenix Completes Capital Reduction Following RSA Write-Off | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EIRGENIX INC. | Biopharmaceuticals | -2.45% | -3.82% | -22.53% | -27.69% | -55.94% | 449M |  |  |  |
- Stock Market
- Stocks
- 6589 Stock
- Charts EirGenix Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
